Wednesday, June 11, 2025

Healthcare

Tempus AI
The AI-enabled clinical assistant is available to query patient data across the EHR as well as build custom agents to maximize workflow Tempus AI, a technology company leading the adoption of AI to advance precision medicine and patient care, announced the expansion of Tempus One—its generative AI clinical assistant—with direct...
Improzo
Improzo announced the appointment of Jane Urban as Chief Data & Analytics Officer, effective June 2, 2025. Ms. Urban will report directly to Chief Technology Officer Abhishek Trigunait and join Improzo’s Executive Team, marking a significant step in the company’s commitment to data-driven innovation. As Chief Data & Analytics Officer...
Tevogen
Tevogen, provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™. Tevogen.AI™ aims to integrate advanced machine learning and predictive modeling into Tevogen Bio’s proprietary ExacTcell™ technology to significantly enhance its target identification and pre-clinical processes, thereby strengthening the Company’s pipeline of innovative immunotherapies, accelerating clinical timelines, and...
Tempus AI
The initiative will apply its massive, multimodal dataset to build models that aim to improve diagnostic, prognostic, and predictive modeling Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced the launch of its Fuses program. This initiative will harness Tempus’...
Vaniam Group
Vaniam Group™, a leader in medical communications, is proud to announce the launch of Vaniam Intelligence™, our platform that integrates proprietary artificial intelligence (AI) with human expertise to transform how biopharma companies develop strategies and make decisions. Designed to deliver actionable insights early, Vaniam Intelligence empowers clients to stay...
Transcripta Bio
Transcripta Bio announced a research collaboration with Microsoft Research to accelerate the discovery of disease-gene associations using advanced artificial intelligence (AI) and large-scale transcriptomic data. This collaboration brings together Transcripta Bio's proprietary Drug-Gene Atlas, which contains over a billion gene responses and full-transcriptome data, and Microsoft Research's machine learning...
RoundUp
Here is AITech365’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the nuances that follow the news. In Automation in AI news this week… ACI Infotech Launches ArqAI, Enterprise AI Platform ACI Infotech, a global technology services firm helping enterprises modernize...
Voiant
Voiant Hub 2.0 is the newest version of Voiant trusted platform that is set to transform the industry. At the core of this innovation is Voiant ReadReady™, a proprietary image flow optimization process developed by Voiant AI Lab. ReadReady™ leverages artificial intelligence to automate quality control and image preparation,...
Trinity
Strategic Collaboration Between Ontada and Trinity Leverages Advanced Analytics and Community Oncology Insights to Improve Provider Outreach and Patient Care Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industries, announces a strategic collaboration with Ontada, a McKesson business and leader in community oncology real-world data,...
Rune Labs
Bringing together Rune Labs’ StrivePD AI software and PD GENEration from Parkinson’s Foundation, the Global Parkinson's Genetics Program (GP2) looks to accelerate therapeutic development and deployment Rune Labs, the leader in precision medicine for Parkinson’s disease (PD), announced the launch of a clinical program with Parkinson’s Foundation to accelerate the discovery...